High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 34, Issue 2, 2007, Pages 266-271

  Momohara, Shigeki ^a   Okamoto, Hiroshi ^a   Iwamoto, Takuji ^a   Mizumura, Tamao ^a   Ikari, Katsunori ^a   Kawaguchi, Yasushi ^a   Takeuchi, Masahiro ^b   Kamatani, Naoyuki ^a   Tomatsu, Taisuke ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Cartilage; CCL18 CC chemokine; Pulmonary and activation regulated chemokine; Rheumatoid arthritis; Synovial tissue

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CHEMOKINE CCL18; MESSENGER RNA; PULMONARY AND ACTIVATION REGULATED CHEMOKINE; STROMELYSIN; UNCLASSIFIED DRUG;

ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CHEMOKINES, CC; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOARTHRITIS, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 33847005382     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52:39-47.
2. Muller-Ladner U. Molecular and cellular interactions in rheumatoid synovium. Curr Opin Rheumatol 1996;8:210-20.
3. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
4. Loetscher P, Moser B, Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol 2000;74:127-80.
5. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15.
6. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII: nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-76.
7. Schutyser E, Struyf S, Wuyts A, et al. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol 2001;31:3755-62.
8. Hieshima K, Imai T, Baba M, et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997;159:1140-9.
9. Kodelja V, Müller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998;160:1411-8.
10. Guan P, Burghes AHM, Cunningham A, et al. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/ SCYA18. Genomics 1999;56:296-302.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Yamanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase-3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
13. Borzi RM, Mazzetti I, Marcu KB, Facchini A. Chemokines in cartilage degradation. Clin Orthop 2004;427 Suppl:S53-61.
14. Kunkel SL. Through the looking glass: the diverse in vivo activities of chemokines. J Clin Invest 1999;104:1333-4.
15. Adema GJ, Hartgers F, Verstraten R, et al. A dendritic-cell-derived CC chemokine that preferentially attracts naive T cells. Nature 1997;387:713-7.
16. Kodelja V, Müller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998;160:1411-8.
17. Lindhout E, Vissers JLM, Hartgers FC, et al. The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes. J Immunol 2001;166:3284-9.
18. Broxmeyer HE, Kim CH, Cooper SH, Hangoc G, Hromas R, Pelus LM. Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann NY Acad Sci 1999;872:142-62.
19. Reape TJ, Rayner K, Manning CD, et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 1999;154:365-74.
20. Pardo A, Smith KM, Abrams J, et al. CCL18/DC-CK-1/PARC upregulation in hypersensitivity pneumonitis. J Leukoc Biol 2001;70:610-6.
21. Goebeler M, Trautmann A, Voss A, Bröcker E-B, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 2001;158:431-40.
22. Schutyser E, Struyf S, Proost P, et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 2002;277:24584-93.
23. Radstake TR, van der Voort R, Ten Brummelhuis M, et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis and regulation by Fc gamma receptors. Ann Rheum Dis 2005;64:359-67.